Stay updated on Obinutuzumab in ISN/RPS Class III/IV Lupus Nephritis Clinical Trial
Sign up to get notified when there's something new on the Obinutuzumab in ISN/RPS Class III/IV Lupus Nephritis Clinical Trial page.

Latest updates to the Obinutuzumab in ISN/RPS Class III/IV Lupus Nephritis Clinical Trial page
- Check4 days agoChange DetectedRevision history updated to include v3.4.3 and remove v3.4.2.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedUpdates include a revision note (Revision: v3.4.2) and the addition of a 'Study Status' element in the History view; the underlying study data remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check40 days agoChange DetectedThe record history shows a new revision entry (v3.4.1) replacing the previous v3.4.0; this update is limited to metadata and does not alter any study details or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page now includes a 'Show glossary' option and color-coded highlights to distinguish additions and deletions, with explanatory labels. The revision label has been updated to v3.4.0 and the No FEAR Act Data note wording has changed.SummaryDifference0.6%

- Check62 days agoChange DetectedNew revision v3.3.4 has been added, replacing the previous v3.3.3 in the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision: v3.3.3 has been added to the Record History. The entries 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed.SummaryDifference0.1%

Stay in the know with updates to Obinutuzumab in ISN/RPS Class III/IV Lupus Nephritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Obinutuzumab in ISN/RPS Class III/IV Lupus Nephritis Clinical Trial page.